Kodiak Sciences (KOD) Competitors $9.25 -0.67 (-6.75%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$9.34 +0.09 (+0.97%) As of 09/12/2025 06:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KOD vs. IRON, BEAM, CNTA, BLTE, AGIO, HRMY, ANIP, ARQT, DYN, and RXRXShould you be buying Kodiak Sciences stock or one of its competitors? The main competitors of Kodiak Sciences include Disc Medicine (IRON), Beam Therapeutics (BEAM), Centessa Pharmaceuticals (CNTA), Belite Bio (BLTE), Agios Pharmaceuticals (AGIO), Harmony Biosciences (HRMY), ANI Pharmaceuticals (ANIP), Arcutis Biotherapeutics (ARQT), Dyne Therapeutics (DYN), and Recursion Pharmaceuticals (RXRX). These companies are all part of the "pharmaceutical products" industry. Kodiak Sciences vs. Its Competitors Disc Medicine Beam Therapeutics Centessa Pharmaceuticals Belite Bio Agios Pharmaceuticals Harmony Biosciences ANI Pharmaceuticals Arcutis Biotherapeutics Dyne Therapeutics Recursion Pharmaceuticals Kodiak Sciences (NASDAQ:KOD) and Disc Medicine (NASDAQ:IRON) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment. Is KOD or IRON more profitable? Disc Medicine's return on equity of -26.60% beat Kodiak Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Kodiak SciencesN/A -155.27% -63.29% Disc Medicine N/A -26.60%-24.58% Does the media prefer KOD or IRON? In the previous week, Disc Medicine had 5 more articles in the media than Kodiak Sciences. MarketBeat recorded 11 mentions for Disc Medicine and 6 mentions for Kodiak Sciences. Disc Medicine's average media sentiment score of 1.56 beat Kodiak Sciences' score of 1.14 indicating that Disc Medicine is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kodiak Sciences 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Disc Medicine 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has higher valuation and earnings, KOD or IRON? Disc Medicine is trading at a lower price-to-earnings ratio than Kodiak Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKodiak SciencesN/AN/A-$176.21M-$3.80-2.43Disc MedicineN/AN/A-$109.36M-$4.47-13.38 Do institutionals and insiders hold more shares of KOD or IRON? 89.1% of Kodiak Sciences shares are owned by institutional investors. Comparatively, 83.7% of Disc Medicine shares are owned by institutional investors. 45.9% of Kodiak Sciences shares are owned by company insiders. Comparatively, 3.6% of Disc Medicine shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, KOD or IRON? Kodiak Sciences has a beta of 2.44, suggesting that its share price is 144% more volatile than the S&P 500. Comparatively, Disc Medicine has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Do analysts prefer KOD or IRON? Kodiak Sciences presently has a consensus target price of $11.75, suggesting a potential upside of 27.03%. Disc Medicine has a consensus target price of $98.30, suggesting a potential upside of 64.33%. Given Disc Medicine's stronger consensus rating and higher possible upside, analysts clearly believe Disc Medicine is more favorable than Kodiak Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kodiak Sciences 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Disc Medicine 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 SummaryDisc Medicine beats Kodiak Sciences on 9 of the 14 factors compared between the two stocks. Get Kodiak Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KOD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KOD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KOD vs. The Competition Export to ExcelMetricKodiak SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$488.60M$3.15B$5.79B$10.19BDividend YieldN/A2.32%5.73%4.60%P/E Ratio-2.4321.4375.4026.02Price / SalesN/A419.38514.85113.09Price / CashN/A44.4425.8129.91Price / Book3.239.6112.166.25Net Income-$176.21M-$53.29M$3.29B$270.76M7 Day Performance-12.07%0.13%0.74%3.87%1 Month Performance-7.87%5.55%5.00%5.49%1 Year Performance241.33%10.44%62.55%25.86% Kodiak Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KODKodiak Sciences3.9413 of 5 stars$9.25-6.8%$11.75+27.0%+241.3%$488.60MN/A-2.4390News CoverageIRONDisc Medicine3.2278 of 5 stars$61.91+1.9%$98.30+58.8%+25.2%$2.11BN/A-13.8530News CoveragePositive NewsHigh Trading VolumeBEAMBeam Therapeutics2.8498 of 5 stars$19.94-4.5%$48.45+143.0%-21.7%$2.11B$63.52M-4.43510Analyst DowngradeCNTACentessa Pharmaceuticals3.1415 of 5 stars$18.03+14.6%$31.45+74.5%+28.4%$2.11B$6.85M-10.07200News CoverageInsider TradeHigh Trading VolumeBLTEBelite Bio2.57 of 5 stars$67.51+2.7%$96.67+43.2%+42.3%$2.09BN/A-43.5510News CoverageAGIOAgios Pharmaceuticals4.3208 of 5 stars$36.41+1.1%$56.00+53.8%-21.2%$2.09B$40.88M3.31390Insider TradeHRMYHarmony Biosciences4.608 of 5 stars$35.83-0.4%$51.00+42.3%-16.8%$2.07B$714.73M11.56200Positive NewsHigh Trading VolumeANIPANI Pharmaceuticals3.9322 of 5 stars$95.20-0.2%$88.25-7.3%+67.0%$2.07B$747.40M-123.63600ARQTArcutis Biotherapeutics2.1937 of 5 stars$17.33+1.0%$19.80+14.3%+62.2%$2.06B$196.54M-23.11150News CoverageInsider TradeDYNDyne Therapeutics3.9312 of 5 stars$13.30-6.5%$34.07+156.1%-61.4%$2.02BN/A-3.45100Positive NewsRXRXRecursion Pharmaceuticals2.151 of 5 stars$4.62+0.2%$7.25+56.9%-26.5%$2.00B$58.84M-2.60400News CoverageAnalyst ForecastOptions VolumeGap Up Related Companies and Tools Related Companies IRON Competitors BEAM Competitors CNTA Competitors BLTE Competitors AGIO Competitors HRMY Competitors ANIP Competitors ARQT Competitors DYN Competitors RXRX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KOD) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredTrump’s right about Epstein.A crisis that could devastate your wealth, upend the dollar, and accelerate the collapse of America’s economy....Porter & Company | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kodiak Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kodiak Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
